Home
Search
Human Health

Vaccines & Biodefense

In the U.S., the recommended immunization series prevents approximately 33,000 deaths each year. Advancements in biotechnology have made it possible to produce vaccines that cannot transmit a virus or bacterium. This method has helped create more than 20 new vaccines against infectious agents, improved existing vaccines, and increased the amount of vaccine that can be produced.

Coronavirus
Biotech Response to COVID-19

As the threat of the novel coronavirus continues to grow globally, innovative biopharmaceutical companies are ramping up efforts to study the virus and develop vaccines and cures to protect individuals from contracting the virus.

Learn More
Blog Posts
Browse all Blogs
Right Mix Matter Diversity Toolkit
The Pandemic Highlights Need for More Women Scientists
July 27, 2021
Young women should be encouraged to pursue careers in science By Sulagna Bhattacharya CEO, Nanoscope Therapeutics, Bedford Texas With our nation emerging from the devastating COVID-19 pandemic, this is a good time to…
Covid Vaccine
COVAX continues to promote equity as a cornerstone of global vaccine distribution
June 3, 2021
As the world continues to contend with the challenges of  the COVID-19 pandemic, one of the most important ways that the virus is being combatted is through COVAX, the global mechanism for equitable access to COVID…
Covid Vaccine
We Can and Must SHARE Vaccines with the Globe
May 24, 2021
What will it take to end the pandemic? A true return to normalcy includes international travel and the movement of people globally. But how do we do this safely? How do we get vaccines to poorer areas of the world? As…
Press Releases
Browse all Press Releases
BIO Cheers Biden Announcement to Share 20 Million Doses of Vaccines with Developing Nations
May 18, 2021
"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE” program, we’ve made clear the urgent need to…
Proposed “TRIPS” Waiver Is the WRONG Way To Attack Global Access for Vaccines to Developing Countries
April 20, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), yesterday sent a letter to U.S. Trade Representative (USTR) Ambassador Katherine Tai sharing BIO perspectives regarding the proposed WTO “TRIPS waiver” for COVID related products. The letter, written…
BIO Welcomes Collaboration With New HHS, USTR Leaders
March 18, 2021
The Biotechnology Innovation Organization (BIO) welcomes the confirmations this week of Katherine Tai to the position of U.S. Trade Representative (USTR) and Xavier Becerra to lead the Department of Health and Human Services (HHS).  The United States leads the world in biotechnology…
Letters, Comments & Testimony
Browse all Letters, Comments & Testimony
BIO Comments on Cures 2.0 Discussion Draft
July 22, 2021
The Biotechnology Innovation Organization (BIO) is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. Our mission is to advance…
BIO Submits Comments on FDA Manufacturing, Supply Chain, and Inspections Guidances & Report
July 16, 2021
On Wednesday, July 14th, BIO submitted comments on FDA’s Guidances: 1) Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency Guidance; 2) Updated Manufacturing, Supply Chain, and Drug and Biological Product Inspections…
BIO Letter to Angela Merkel on the Benefits of Biotech
July 15, 2021
As you prepare for Chancellor Merkel’s visit to Washington, we, the representatives of America’s biotechnology sector thought that you and your government might benefit from an update on all that our sector is doing globally to address the ongoing COVID crisis, and in particular to ensure that…
Join BIOAction
Become an Advocate for Biotechnology

Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.

Join BIOAction
Placeholder Image
favorite Created with Sketch.
Coronavirus